Roy Hantgan to Protein Binding
This is a "connection" page, showing publications Roy Hantgan has written about Protein Binding.
Connection Strength
0.660
-
Hantgan RR, Stahle MC, Lord ST. Dynamic regulation of fibrinogen: integrin aIIbß3 binding. Biochemistry. 2010 Nov 02; 49(43):9217-25.
Score: 0.079
-
Hantgan RR, Stahle MC. Integrin priming dynamics: mechanisms of integrin antagonist-promoted alphaIIbbeta3:PAC-1 molecular recognition. Biochemistry. 2009 Sep 08; 48(35):8355-65.
Score: 0.073
-
Rocco M, Rosano C, Weisel JW, Horita DA, Hantgan RR. Integrin conformational regulation: uncoupling extension/tail separation from changes in the head region by a multiresolution approach. Structure. 2008 Jun; 16(6):954-64.
Score: 0.067
-
Hantgan RR, Stahle MC, Horita DA. Entropy drives integrin alphaIIbbeta3:echistatin binding--evidence from surface plasmon resonance spectroscopy. Biochemistry. 2008 Mar 04; 47(9):2884-92.
Score: 0.066
-
Hantgan RR, Stahle MC, Connor JH, Connor RF, Mousa SA. AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists. J Thromb Haemost. 2007 Mar; 5(3):542-50.
Score: 0.061
-
Hantgan RR, Stahle MC, Connor JH, Horita DA, Rocco M, McLane MA, Yakovlev S, Medved L. Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling. Protein Sci. 2006 Aug; 15(8):1893-906.
Score: 0.059
-
Mizel SB, West AP, Hantgan RR. Identification of a sequence in human toll-like receptor 5 required for the binding of Gram-negative flagellin. J Biol Chem. 2003 Jun 27; 278(26):23624-9.
Score: 0.047
-
Lyles DS, McKenzie MO, Hantgan RR. Stopped-flow, classical, and dynamic light scattering analysis of matrix protein binding to nucleocapsids of vesicular stomatitis virus. Biochemistry. 1996 May 21; 35(20):6508-18.
Score: 0.029
-
Ferluga S, Hantgan R, Goldgur Y, Himanen JP, Nikolov DB, Debinski W. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase. J Biol Chem. 2013 Jun 21; 288(25):18448-57.
Score: 0.024
-
Nguyen V, Conyers JM, Zhu D, Gibo DM, Hantgan RR, Larson SM, Debinski W, Mintz A. A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Ra2 tumor-restricted biomarker. Neuro Oncol. 2012 Oct; 14(10):1239-53.
Score: 0.023
-
Lema Tomé CM, Palma E, Ferluga S, Lowther WT, Hantgan R, Wykosky J, Debinski W. Structural and functional characterization of monomeric EphrinA1 binding site to EphA2 receptor. J Biol Chem. 2012 Apr 20; 287(17):14012-22.
Score: 0.022
-
Ramsamooj P, Doellgast GJ, Hantgan RR. Inhibition of fibrin(ogen) binding to stimulated platelets by a monoclonal antibody specific for a conformational determinant of GPIIIa. Thromb Res. 1990 Jun 15; 58(6):577-92.
Score: 0.019
-
Tsurupa G, Hantgan RR, Burton RA, Pechik I, Tjandra N, Medved L. Structure, stability, and interaction of the fibrin(ogen) alphaC-domains. Biochemistry. 2009 Dec 29; 48(51):12191-201.
Score: 0.019
-
Shen K, Sergeant S, Hantgan RR, McPhail LC, Horita DA. Mutations in the PX-SH3A linker of p47phox decouple PI(3,4)P2 binding from NADPH oxidase activation. Biochemistry. 2008 Aug 26; 47(34):8855-65.
Score: 0.017
-
Hantgan RR. Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: evidence for a common mechanism. Biochim Biophys Acta. 1988 Jan 18; 968(1):24-35.
Score: 0.016
-
O'Flaherty JT, Rogers LC, Paumi CM, Hantgan RR, Thomas LR, Clay CE, High K, Chen YQ, Willingham MC, Smitherman PK, Kute TE, Rao A, Cramer SD, Morrow CS. 5-Oxo-ETE analogs and the proliferation of cancer cells. Biochim Biophys Acta. 2005 Oct 01; 1736(3):228-36.
Score: 0.014
-
Tsurupa G, Veklich Y, Hantgan R, Belkin AM, Weisel JW, Medved L. Do the isolated fibrinogen alphaC-domains form ordered oligomers? Biophys Chem. 2004 Dec 20; 112(2-3):257-66.
Score: 0.013
-
Chen K, Ballas SK, Hantgan RR, Kim-Shapiro DB. Aggregation of normal and sickle hemoglobin in high concentration phosphate buffer. Biophys J. 2004 Dec; 87(6):4113-21.
Score: 0.013